Quarterly report pursuant to sections 13 or 15(d)

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)

v2.4.0.6
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)
Jul. 31, 2012
Oct. 31, 2011
Accounts Payable $ 4,947,357 $ 4,778,508
Salaries and other compensation 696,645 531,040
Clinical Trial 56,468 0
Vendors 77,512 0
Consultants 32,200 32,200
Financing Costs 140,492 0
Legal 81,231 46,346
Other 21,768 8,500
Total accounts payable & accured expenses $ 6,053,853 $ 5,396,594